DMRP, an ABC transporter encoded by the dMRP/CG6214 gene, is the Drosophila melanogaster orthologue of the "long" human multidrug resistance-associated proteins (MRP1/ABCC1, MRP2/ABCC2, MRP3/ABCC3, MRP6/ABCC6, and MRP7/ABCC10). In order to provide a detailed biochemical characterisation we expressed DMRP in Sf9 insect cell membranes. We demonstrated DMRP as a functional orthologue of its human counterparts capable of transporting several human MRP substrates like β-estradiol 17-β-D-glucuronide, leukotriene C 4 , calcein, fluo3 and carboxydichlorofluorescein. Unexpectedly, we found DMRP to exhibit an extremely high turnover rate for the substrate transport as compared to its human orthologues. Furthermore, DMRP showed remarkably high basal ATPase activity (68-75 nmol P i /mg membrane protein/min), which could be further stimulated by probenecid and the glutathione conjugate of N-ethylmaleimide. Surprisingly, this high level basal ATPase activity was inhibited by the transported substrates. We discussed this phenomenon in the light of a potential endogenous substrate (or activator) present in the Sf9 membrane.
Introduction
The ATP-binding cassette transporters (ABC transporters), constituting one of the major classes of membrane transporters, have been found ubiquitously in all species studied so far. The majority of these integral membrane proteins utilise the energy of ATP-binding and -hydrolysis to transport substrates across biological membranes [1] . Though some bacterial ABC transporters facilitate the import of nutrients [2] , all eukaryote ABC transporters characterised to date transport their substrates from the cytoplasm either to cellular organelles or out of the cell, thus playing essential roles in many cellular processes such as the elimination of endo-and xenobiotics, and the transport of excretory compounds. Besides their physiological relevance, ABC transporters have clinical and economical significance as well, since some confer resistance to antibiotics, chemotherapeutic drugs and herbicides. Of the 48 genes encoding human ABC transporters, 18 have been associated with heritable diseases. [3] .
The minimal functional unit of an ABC transporter consists of two transmembrane domains (TMD 1 , TMD 2 ) and two nucleotide binding domains (NBD 1 , NBD 2 ) [4] . These are presentboth in human and in Drosophilaeither as a single protein (full transporters) or as a homo-or heterodimer of two half transporters. Each nucleotide binding domain includes three conserved motifs: the Walker A and B motifs that are commonly observed in ATP binding proteins [5] , and the Signature C motif that is unique to ABC transporters [6] . The transmembrane domains TMD1 and TMD2 are composed of six transmembrane helices. A subset of the ABCC subfamily members ("long" MRPs) possesses an additional Nterminal transmembrane domain (TMD 0 )consisting of 5 transmembrane helicesand a large cytoplasmic loop (L 0 ) connecting TMD 0 to TMD1 [7, 8] . This domain organization is characteristic to MRP1, MRP2, MRP3, MRP6, SUR1, SUR2 and MRP7 in humans, while in Drosophila, among the 56 ABC proteins, it is present in DSUR and DMRP only [9] . dSUR has been identified as the functional orthologue of the mammalian SUR2 [10, 11] , coding for the regulatory subunit of the ATP-sensitive potassium (K ATP ) channel complex. Recent data suggest that dSUR plays a protective role against hypoxic stress and heart failure [12] . The physiological role of dMRP has not yet been identified.
A phylogenetic analysis revealed that DMRP is the orthologue of human "long" multidrug resistance-associated proteins MRP1, MRP2, MRP3 and MRP6 [13] . The typical membrane topology of these human MRPs, which was verified experimentally for MRP1 [14] [15] [16] [17] , has also been proposed for DMRP previously [13] . The dMRP/CG6214 gene spans 22 kb of genomic DNA and contains 19 exonic sequences. Nine of them are alternatively spliced for two internally variable exons giving rise to the maximum of fourteen possible transcripts [18] . The existence of different mRNA isoforms, each harbouring 12 exons and all but one coding for transcripts of the same size, was experimentally demonstrated. [18] . Our previous Northern blot and in situ hybridisation analysis, based on the SD07655 dMRP clone coding for the 4b 8d isoform confirmed that dMRP is expressed in embryonic, larval, pupal, and adult life stages, with enriched expression in the 0-2 h embryos and adult brain [13] . For the biochemical characterisation of the transporter we have expressed DMRP in the Sf9/baculovirus expression system and demonstrated that DMRP is a vanadatesensitive organic anion transporter, capable of transporting the inflammatory mediator LTC 4 , a well-known substrate of the human "long" MRPs [13] .
In the present study we provide a comparative analysis of the functional characteristics of DMRP and the human "long" MRPs. Our results indicate that DMRP possesses an unusually high transport capacity for known human MRP substrates. Moreover it exhibits a unique high level basal ATPase activity that is surprisingly inhibited by the transported substrates, however the basal ATPase activity can be further stimulated by the addition of some other compounds. In the discussion section we provide a hypothesis for the above phenomenon. Ouabain was purchased from Fluka. The anti-DMRP polyclonal antiserum pAB7655 was raised against a synthetic peptide corresponding to amino acids 209-222 of DMRP (ZYMED Laboratories Inc.) as described [13] . The anti-MRP1 and anti-MRP2 monoclonal antibodies m6 and M 2 I-4 were a kind gift of R. Scheper. Secondary HRPconjugated anti-rabbit and anti-mouse antibodies were purchased from Jackson ImmunoResearch. Nitrocellulose membrane filters (HAWP02500) were obtained from Millipore, and the scintillation fluid (Opti-fluor) from PerkinElmer. All other compounds were obtained from Sigma Aldrich.
Materials and methods

Materials
Expression, membrane preparation and immunoblotting
Recombinant baculovirus containing the dMRP cDNA (SD07655) coding for isoform 4b 8d was prepared as described previously [13] . MRP1 and MRP2 expression was generated using recombinant baculovirus as described previously [19] . Sf9 cells were cultured and infected with the recombinant baculovirus. After 3-days of virus infection the Sf9 cells were harvested, the membranes were isolated and stored at −70°C as described by Sarkadi et al. [20] . Total membrane protein concentrations were determined by the modified Lowry method [21] . Gel electrophoresis and immunoblotting were performed as described previously [20] using the anti-DMRP polyclonal antiserum pAB7655 (1:500) or m6 and M 2 I-4 (1:10,000). The protein-antibody interaction was visualized by the enhanced chemiluminescence technique (ECL, Amersham Biosciences) using an anti-rabbit (1:10,000) or anti-mouse (1:10,000) horseradish peroxidase-conjugated secondary antibodies. A quantitative measure of expression was determined by densitometry of the immunoblots or gels stained with Coomassie Blue, using Quantity One software (Bio-Rad).
Vesicular transport measurements
Vesicular transport of radiolabelled substrates were measured using a rapid filtration method [19, 22] . Briefly, isolated inside-out Sf9 membrane vesicles containing 100 μg or 2 μg membrane protein (as indicated) were incubated in the presence of 4 mM MgATP or MgAMP in 150 μl of transport buffer (6 mM MgCl 2 , 40 mM MOPS-Tris, pH 7.0, 40 mM KCl) at 23°C (LTC 4 ) or at 37°C (E 2 17βDG). Incubation was stopped by the addition of 800 μl of ice-cold washing buffer (40 mM MOPS-Tris, pH 7.0, 70 mM KCl) at the time points indicated. Samples were filtered quickly through 0.45 μm nitrocellulose membrane filters (Millipore). The filters were washed twice with 5 ml of cold washing buffer and the filter-bound radioactivity was measured in scintillation fluid (Opti-fluor, Perki-nElmer) using a Wallac 1409 DSA scintillation counter. ATPdependent transport was calculated by subtracting the activity values obtained in the presence of AMP from those in the presence of ATP. For these experiments, different membrane preparations having a similar proportion of inside-out vesicles were used. The relative amount of uptake-competent inside-out vesicles was determined by measuring the rate of endogenous ATP-dependent 45 Ca 2+ uptake of each membrane preparation using a rapid filtration method described previously [22] . Transport values were corrected for non-specific transport observed in the β-galactosidase-expressing control membranes. The Michaelis-Menten kinetic parameters of transport have been determined either from the x-y intersections of the Lineweaver-Burk plots or from non-linear regressions of the concentration curves using KaleidaGraph (Synergy Software), as indicated. Data points depicted in the figures show the mean values of at least three independent determinations conducted in duplicates. Error bars depict the standard error of mean value (S.E.M.).
For the fluorescent substrates, vesicular transport measurements were performed on uptake-competent inside-out Sf9 vesicles containing 100 μg membrane protein in the presence of 6 mM MgATP or MgAMP in 100 μl of transport buffer (6 mM MgCl 2 , 40 mM MOPS-Tris, pH 7.0, 40 mM KCl) at 37°C at the indicated substrate concentrations, and incubation times. Samples were diluted in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 ) and a FACSCalibur flow cytometer (Becton-Dickinson, San Jose, CA, USA), equipped with a 488 nm argon-ion laser and a 525 ± 10 nm bandpass filter was used to determine the fluorescence intensity of the dyes accumulated in the membrane vesicles. All data were collected and evaluated by CellQuest software (Becton-Dickinson, San Jose, CA, USA). A total of 10,000 vesicles were counted in each experiment. The geometric mean values of histograms of AMP-containing samples were subtracted from the geometric mean values of histograms of ATP-containing samples, and ATP dependent differences were depicted in the figures. Figures represent at least three independent determinations. The corresponding standard error of mean value (S.E.M.) is depicted.
ATPase activity measurements
The vanadate-sensitive ATPase activity was measured by colorimetric detection of inorganic phosphate liberation as described previously [19, 20] . In brief, membrane suspensions containing 30 μg of membrane protein were incubated at 37°C for 5 min in 150 μl of a medium containing 40 mM MOPS-Tris, pH 7.0, 0.5 mM EGTA-Tris, 2 mM dithiothreitol, 50 mM KCl, 5 mM sodium azide, and 1 mM ouabain. The ATPase reaction was started by the addition of 3.3 mM MgATP. The indicated drugs were added in DMSO, except for LTC 4 that was diluted in the above assay mix. The final concentration of DMSO in the assay medium was less than 1%. The reactions were stopped by the addition of 0.1 ml of 5% SDS. The amount of inorganic phosphate generated was determined based on a colorimetric reaction. The optical density was read at 700 nm after 15 min incubation. ATPase activity was calculated by the difference obtained in P i levels between 0-min reaction (stopped immediately with SDS) and reactions after the 5-minute incubation periods. The differences between the ATPase activities measured in the absence and presence of 1.33 mM vanadate were taken and activities were corrected for non-specific activity observed in the β-galactosidase-expressing control membranes. Data points depict the mean values of at least three independent determinations conducted in duplicates at a minimum. Error bars depict the standard error of the mean value (S.E.M.).
Results
Transport properties of DMRP
In order to investigate the transport characteristics of DMRP we have expressed the protein in Sf9 insect cells and studied the ATPdependent uptake of radiolabelled human MRP substrates, the estrogen metabolite β-estradiol 17-β-D-glucuronide (E 2 17βDG) and the inflammatory mediator leukotriene C 4 (LTC 4 ) in isolated Sf9 membrane vesicles. The initial linear phase of the transport was determined and the ATP-dependent transport values were corrected with the almost negligible uptake measured in β-galactosidase expressing control Sf9 membranes.
As demonstrated in the inset of Fig. 1A , at 37°C, DMRP-dependent transport of 1 μM E 2 17βDG provided a good approximation of the initial transport rate at 30 s. Therefore, these conditions were used to study the concentration dependent uptake of E 2 17βDG (Fig. 1A) . The kinetic parameters of transport were determined from the Lineweaver-Burk plot (Fig. 1B) . The apparent K m value was found to be 344 ± 182 μM and the maximum rate of transport was 50 ± 25 nmol/mg of membrane protein/min. Due to the low solubility of the compound, the concentration dependence at higher concentrations could not be measured. Therefore these kinetic parameters have to be considered as best estimates.
We found DMRP to exhibit an extremely high turnover rate for LTC 4 transport. To measure initial velocity, we reduced the amount of vesicles 50 times to 2 μg total membrane protein/sample, and measured LTC 4 transport of DMRP at 23°C. In comparison, MRP1dependent LTC 4 transport was measured at 37°C in vesicles containing 100 μg total membrane protein/sample. In control experiments we measured the transport activity values of mixed vesicle preparations (using 10 μg DMRP, and 90 μg β-galactosidase or 1 μg DMRP and 9 μg β-galactosidase vesicles), in parallel with 10 μg or 1 μg vesicles exclusively overexpressing DMRP. We obtained similar results for the mixed vesicle controls and the vesicles expressing DMRP (results not shown), suggesting that the dramatic reduction of the vesicular content did not result in unspecific changes. Therefore, we performed the experiments on 2 μg total membrane protein containing vesicles obtained from DMRP over-expressing Sf9 cells. The time-course of LTC 4 uptake in 2 μg isolated vesicles at 23°C, 50 nM LTC 4 is demonstrated in the left-hand-side inset of Fig. 2A . Kinetic parameters of DMRP-mediated LTC 4 transport were determined at 30 s, while for MRP1 we used the generally accepted conditions reflecting the initial rate of transport (100 μg protein, 23°C, 30 s). The uptake was a saturable function of the LTC 4 concentration for both DMRP and MRP1 ( Fig. 2A) . We calculated the kinetic parameters from the Lineweaver-Burk plots (Fig. 2B) as the maximum uptake rates of 3038 ± 666 pmol/ mg of membrane protein/min and 73 ± 15 pmol/mg of membrane protein/min; and the apparent K m values of 231 ± 60 nM and 187 ± 47 nM for DMRP and MRP1, respectively. The vesicles contained similar amounts of over-expressed proteins as detected by Coomassie staining (data not shown).
We also investigated the effect of known human MRP inhibitors on the E 2 17βDG and LTC 4 transport. The organic anions probenecid (PB), benzbromarone (BB), indomethacin (IM), and the leukotriene receptor antagonist MK571 effectively inhibited both E 2 17βDG and LTC 4 transport of DMRP (Figs. 1C and 2C) in a concentration range relevant for the "long" human orthologues [19, 23, 24] . We investigated the ability of DMRP to transport [ 3 H] 3′-5′-cyclic adenosine mono-phosphate (cAMP), substrate of the short MRPs (MRP4 [25] and MRP5 [26] ), as well. We used 100 μg transport competent vesicles at 37°C at the concentration of 10-100 μM cAMP for 10 minute incubation. In parallel we tested the LTC 4 transport activity of DMRP to monitor DMRP-function. We didn't detect any ATP dependent transport of cAMP, suggesting that cAMP is not a substrate for DMRP.
We used flow cytometry to test the ability of DMRP to transport fluorescent human MRP substrates. We investigated the DMRP, MRP1 and MRP2 dependent uptake of calcein, Fluo3, and carboxydichlorofluorescein (CDCF) at 37°C, in the presence of 6 mM MgATP or MgAMP. We measured the uptake of the fluorescent substrates as a function of the incubation time, and used incubation times within the linear range to determine the kinetic parameters of the transports. Due to the lack of calibration, the apparent V max values, always determined under identical experimental conditions, are only arbitrary units suitable for representing turnover differences of the transporters. Coomassie staining revealed that the vesicles investigated in FACS measurements all contained similar amount of overexpressed proteins (data not shown).
In case of calcein we could only detect DMRP-dependent transport activity, possibly due to the relatively low sensitivity of the assay. Time-course showed approximate linearity up to 60 s at 37°C ( Fig. 3 inset), therefore we used these conditions to measure transport activity as a function of calcein concentration (Fig. 3) . We determined the apparent K m of the calcein transport as 1.15 ± 0.17 μM for DMRP applying non-linear regression of the concentration curve.
For fluo3 we could detect significant transport activity for DMRP and MRP2, but not for MRP1. Time-course for fluo3 showed approximate linearity up to 0.5 and 1 min for DMRP and MRP2 at 37°C, respectively (Fig. 4A ), and these conditions were used to determine the apparent kinetic parameters (Fig. 4B ). We determined the K m values for DMRP and MRP2 from non-linear regression of the concentration curve. The apparent K m values are 0.37 ± 0.13 μM for DMRP and 0.81 ± 0.40 μM for MRP2. The difference between the arbitrary turnover rates determined in the same experiments for DMRP and MRP2 was remarkable. We detected 8.4 times higher activity for DMRP than for MRP2, while the vesicles contained similar amounts of overexpressed proteins (data not shown).
In case of CDCF, the DMRP-dependent dye accumulation was prominent, while a moderate activity was detected for MRP2 and a threshold level of transport activity for MRP1. Therefore we only investigated the activity of the aforementioned two transporters. Time-course showed approximate linearity at 37°C up to 0.5 and 1 min for DMRP and MRP2, respectively ( Fig. 5 inset) . Therefore these conditions were applied to determine kinetic parameters of the CDCF transport ( Fig. 5 ). Since we detected an unspecific ATP independent effect of CDCF on the transport assay above 50 μM CDCF concentration, we only used and presented data up to 25 μM CDCF concentrations. This interval included the effective concentration range of CDCF for DMRP but not for MRP2. Therefore applying non-linear regression we could only determine the K m values of the DMRP dependent transport as 4.1 ± 0.6 μM CDCF.
The ATP-dependent tracer uptake of the β-galactosidase control membranes showed negligible background transport activity for the three fluorescent substrates (data not shown).
The MRP specific inhibitor MK571 effectively inhibited the accumulation of calcein, fluo3 and CDCF in DMRP over-expressing Sf9 vesicles at a concentration of 30 μM (data not shown).
The ATPase activity of DMRP; effect of substrates and inhibitors
Transported substrates of ABC-transporters are known to influence ATPase activity most commonly by increasing the rate of ATP hydrolysis (substrate-stimulated ATPase activity) [20] . To investigate the interaction between the substrates and the transporter we characterised the ATPase activity of the transporter in the absence or in the presence of different compounds (Fig. 6) . The vanadate-sensitive basal and 5 mM NEM-GS stimulated ATPase activities of DMRP were found to show approximate linearity up to 5 min at 37°C and 3.3 mM Mg 2+ ATP concentration (Fig. 6A ). As depicted in Fig. 6B , both vanadate-sensitive basal and 5 mM NEM-GS stimulated activities were saturated above 2 mM Mg 2+ ATP concentration. To further characterise the ATPase activity of the transporter we investigated its vanadate-sensitive ATPase activity in response to NEM-GS, probenecid, LTC 4 , and E 2 17βDG (Fig. 6C) . Control membranes from cells expressing β-galactosidase had a low level basal ATPase activity (5-8 nmol P i /mg of membrane protein/min) independent of the presence of the tested compounds (data not shown). The vanadate-sensitive ATPase activity of DMRP in the absence of any substrate was unusually high (68-75 nmol P i /mg of membrane protein/min) compared to that of human MRP1 (6-8 nmol P i /mg of membrane protein/min), [19, 23] . The basal activity could be stimulated 1.9 fold in the presence of the synthetic glutathione-conjugate, NEM-GS (2.5 mM), and 1.8 fold in the presence of the organic anion probenecid (1 mM) ( Fig. 6C) . Interestingly, all of the investigated DMRP transport substrates (LTC 4 , calcein, and E 2 17βDG) inhibited the basal ATPase activity. The inhibited (residual) activity was 46% for LTC 4 , 77% for calcein (data not shown) and 12.5% for E 2 17βDG, at the highest concentrations used (Fig. 6C ). The IC 50 values for LTC 4 and E 2 17βDG in ATPase activity measurements correlated well with the apparent K m values determined in the transport experiments. The specific MRP inhibitor MK571 inhibited both the NEM-GS stimulated and the basal ATPase activity in a concentration dependent manner with IC 50 values of 1.05 and 2.05 μM, respectively (Fig. 6D) .
Discussion
The present study focused on a detailed characterisation of DMRP, the only Drosophila melanogaster orthologue of the human "long" MRPs (MRP1, 2, 3, 6, and 7), providing an analysis of Drosophila MRP transport and ATPase activities by comparing them to those of its human orthologues. For such a comparative investigation proteins were expressed in the Sf9/baculovirus expression system and the ability of DMRP to transport different human MRP substrates, such as E 2 17βDG, LTC 4 , calcein, fluo3 and CDCF were tested in vesicular transport experiments.
Human "long" MRPs were shown to transport E 2 17βDG [27] [28] [29] [30] [31] [32] [33] . The majority of these proteins show modest capacity but low K m values (apparent K m of 10-70 μM) for E 2 17βDG with the exception of MRP2, which shows high K m value but is considered to have the highest transport rate for this substrate [34] . We detected 4.6 times higher maximal transport rate for DMRP than for MRP2 in the E 2 17βDG vesicular transport experiments, while the expression level of DMRP in vesicles used for determination of E 2 17βDG transport kinetic parameters was approximately one-fourth of the expression of MRP2. Therefore the maximal transport rate of DMRP is approximately 18 times higher than that of MRP2. We found that the K m of DMRP for this substrate is relatively high, therefore we consider DMRP as a unique high capacity transporter of E 2 17βDG, resembling the properties of MRP2, as both transporters show high K m and transport rate values.
All "long" MRPs are capable of transporting LTC 4 with different transport characteristics [24, 29, 31, 32, 35] . We have investigated the LTC 4 transport properties of DMRP, and found the maximal transport rate of DMRP for LTC 4 approximately 40 times higher than that of the physiologically relevant MRP1, while DMRP possesses slightly higher K m value for LTC 4 than MRP1.
It was previously shown that MRP1 is capable of transporting calcein [36] , while fluo3 is transported by both MRP1 and MRP2 [37] [38] [39] . CDCF was proven to be a substrate for MRP2 and MRP5 [40] . We investigated the ability of DMRP to transport these fluorescent substrates of the human MRPs, and determined their apparent K m values. We detected a high turnover rate for DMRP for all the three fluorescent substrates, while MRP2 investigated in parallel showed only moderate transport activity for fluo3 and CDCF (though these transporters were expressed at similar levels).
We investigated the inhibitor profile of the DMRP-dependent transport and found that the organic anions probenecid, benzbromarone, indomethacin, and the leukotriene receptor antagonist MK571 exhibited potent inhibitory effects on DMRP transport at concentrations that negatively impact the transport properties of the human orthologues as well [19, [22] [23] [24] 34] .
The ATPase activity measurements showed that DMRP has the highest basal activity (68-75 nmol P i /mg membrane protein/min) of any MRP studied to date in Sf9 membrane vesicle preparations [19, 23] . This unusually high basal activity of DMRP could be further stimulated by NEM-GS and probenecid. Surprisingly, all of the investigated DMRP transport substrates inhibited the basal ATPase activity in a concentration dependent manner for the whole effective concentration range (Fig. 6C) .
Collectively, these observations demonstrate that DMRP reflects many properties of the human "long" MRPs including substrate and inhibitor specificity. However, there are several unique features of DMRP revealed by the present study: i) compared to the human transporters, DMRP exhibits a much higher transport activity; ii) DMRP has an unusually high basal ATPase activity; iii) the investigated DMRP substrates inhibit the basal ATPase activity.
The remarkable activity of DMRP compared to that of the human transporters may partially originate from the fact that it is an insect protein expressed in a similar host cell. In addition, we hypothesise that DMRP in the Sf9 membrane is already in an activated state. This could either originate from the presence of endogenous substrate(s) or activator molecule(s) characteristic of Sf9 cells. This activation is presumably not complete, since NEM-GS and probenecid can evoke further activation of the ATPase activity. Nevertheless, this partial activation would imply that the transporter efficiently hydrolyses ATP even in the absence of any external substrate, though an external substrate may successfully compete with the endogenous activator. If such a competitive external substrate is added and the potential of the external substrate to trigger ATP hydrolysis is weaker than that of the endogenous one, an apparent inhibition of the ATPase activity may be detected. Investigations of purified DMRP reconstituted in different membrane environments would shed light onto the relevance of the above hypothesis. The work aiming to obtain active purified protein is on the way.
Another question is whether the high basal activity detected in vitro has any relevance in vivo. It is quite unlikely that an organism would pay the cost for having such an ATP depleting active transporter unless it had a fundamental role in its homeostasis. Since DMRP knock out animals are viable and fertile (http://flybase.org, FlyBase ID: FBti0024660, FBti0057681) and dMRP cDNA is present ubiquitously [13] , it seems that this is not the case. It is more likely that DMRP does not possess such a high basal activity in its natural environment, e.g., due to the lack of such an activator or the presence of some negative regulatory mechanisms.
The present article provides information on the characteristics of DMRP revealing that DMRP possesses combined features of its human orthologues, however exhibiting a remarkably higher activity. These features make DMRP a valuable model protein for further studies to reveal the mechanistic features of MRPs, especially for investigations that require high turnover.
